Pan Tumor Study – Effectively Treatment for HER2-Expressing Cancers Regardless of Tumor Location
Trastuzumab deruxtecan (Enhertu®) is an effective treatment option for patients with difficult-to-treat HER2-expressing solid tumors, according to these findings from an international study uncovering effectiveness across tumor locations.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in